Loading clinical trials...
Loading clinical trials...
A Phase 2 Study to Evaluate the Efficacy of Bortezomib in Patients With De-novo Waldenstrom's Macroglobulinemia and Lymphoplasmacytic Lymphoma
Conditions
Interventions
Bortezomib
Locations
2
South Korea
Seoul National University Bundang Hospital
Seongnam, South Korea
Seoul National University Hospital
Seoul, South Korea
Start Date
November 21, 2016
Primary Completion Date
December 1, 2020
Completion Date
December 1, 2020
Last Updated
November 7, 2017
NCT01804686
NCT04195633
NCT02269592
NCT05602363
NCT04893564
NCT06340737
Lead Sponsor
Seoul National University Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions